ArticleEJHaem2022

Aiding early clinical drug development by elucidation of the relationship between tumor growth inhibition and survival in relapsed/refractory multiple myeloma patients.

Yiming Cheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.